Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata severity is influenced by factors like long disease duration, relapses, treatment response, and mental health, leading to the creation of a new severity measurement tool.

Histopathology is not reliable for detecting early fibrosis in traction alopecia or for showing how severe it is.

CLASI is a valid tool for assessing skin activity and damage in lupus patients.

No significant link between male pattern baldness and COVID-19 severity was found.

Hydroxychloroquine is less effective than betamethasone oral mini pulse therapy for treating alopecia areata.

The model accurately predicts hair loss severity in alopecia areata.

Baricitinib 4 mg should be used for at least 1 year to see significant hair regrowth in severe alopecia areata.

Alopecia Areata is an autoimmune condition causing hair loss, influenced by genetics, environment, and possibly improved by anti-MIF therapy, with many patients experiencing regrowth within a year.

Intralesional steroids improve Alopecia Areata, and trichoscopy effectively tracks this improvement.

People with alopecia areata have much lower Vitamin-D levels than healthy individuals.

The ALADIN score can predict how well patients with alopecia areata will respond to JAK inhibitor treatments.

Calprotectin levels are higher in alopecia areata patients, indicating systemic inflammation.

The HairCheck® device is effective for measuring hair loss and growth in people with alopecia.

Low vitamin D levels are common in people with Alopecia Areata.

Alopecia areata may lead to hearing loss.

Tofacitinib is more effective than traditional treatments for severe alopecia areata in children.

Higher stress levels may worsen alopecia areata, suggesting stress management is important for treatment.

Trichoscopy is useful for detecting and monitoring androgenetic alopecia.

PRP is an effective and safe treatment for hair loss in women.

Treat alopecia areata with personalized plans, using corticosteroids for mild cases and Janus Kinase inhibitors for severe cases, while also offering psychological support.

Upadacitinib effectively improved severe atopic dermatitis and alopecia universalis in a 29-year-old man.

The MDhair app accurately assesses hair loss severity with 94% accuracy.

High retinol intake may worsen hair loss in alopecia areata.

Low-dose acitretin helps nail psoriasis, stem cells may treat scarring alopecia, Chinese men have lower baldness rates, lateral foldplasty is good for ingrown toenails, hair diameter helps diagnose female baldness, childhood trauma linked to alopecia areata, certain hair-weaving leads to scalp conditions in African American women, and new methods for hair research and understanding hair and sweat gland development were introduced.

Intravenous corticosteroid therapy is effective for long-term hair regrowth in alopecia areata, and a scoring system helps predict treatment success and relapse.

Baricitinib was effective in treating severe and very severe alopecia areata after 52 weeks.

Dupilumab effectively reduces alopecia areata symptoms in children with atopic dermatitis.

MRI helps evaluate androgenetic alopecia severity.

Elevated granulysin levels may indicate disease activity in vitiligo and alopecia areata.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.